Literature DB >> 23444065

Malignant neuroendocrine tumors: incidence and outcomes in pediatric patients.

Bassan Allan1, James Davis, Eduardo Perez, John Lew, Juan Sola.   

Abstract

INTRODUCTION: Malignant neuroendocrine tumors (NETs) are rare solid tumors infrequently seen in children. This study examines current incidence trends and outcomes for children with NETs.
MATERIALS AND METHODS: The Surveillance Epidemiology and End Results registry was examined for patients between birth and 19 years of age between 1973 and 2005 with NETs.
RESULTS: Overall, 481 patients were identified with malignant NETs. Tumors were classified as malignant carcinoid (n = 189, 39%), central nervous system tumors (n = 127, 26%), medullary thyroid carcinoma (n = 88, 18%), neuroendocrine carcinoma (n = 50, 10%), pheochromocytoma (n = 17, 3.5%), and paraganglioma (n = 7, 1.5%). Children less than 5 years of age had worse 5-year survival ( < 50 vs. > 76% if older, p = 0.009). Blacks had lower 5-year survival compared with whites (61 vs. 81%, p = 0.001). Tumor locations with favorable prognosis included the appendix, lung, and thyroid ( > 95% 5-year survival), whereas soft tissue and ovary location were associated with poor survival (p < 0.001). In multivariate analysis, distant disease at diagnosis (odds ratio [OR] 14.9; 95% confidence interval [CI], 6.9 to 32.1) and black race (OR 3.3; 95% CI, 1.4 to 7.4) were independent predictors of death.
CONCLUSION: Whites have the highest incidence of pediatric NETs. Colon/rectum, appendix, or thyroid tumor location portends favorable prognosis. Black children and those less than 5 years of age had poorer prognosis. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 23444065     DOI: 10.1055/s-0033-1333643

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  6 in total

1.  Management and outcome of children with neuroendocrine tumors of the appendix in Spain: Is there room for improvement?

Authors:  P Pérez-Albert; T de Rojas; M Á Lendínez; L Illade; M García-Abos; J Alonso-Cadenas; M Andión; L Madero
Journal:  Clin Transl Oncol       Date:  2017-03-28       Impact factor: 3.405

2.  An unusual case of appendicitis due to appendiceal neuroendocrine tumor in a patient: A case report.

Authors:  Tingting Gao; Weijue Xu
Journal:  Exp Ther Med       Date:  2022-06-22       Impact factor: 2.751

3.  Long-term outcomes in pediatric appendiceal carcinoids: Turkey experience.

Authors:  Fatih Akova; Emrah Aydin; Y Nur Eray; Nurseli Toksoy; Senay Yalcin; Serdar Altinay; Umit Seza Tetikkurt
Journal:  Eur J Pediatr       Date:  2018-09-25       Impact factor: 3.183

4.  Patient-specific dosimetry of 99mTc-HYNIC-Tyr3-Octreotide in children.

Authors:  Xinchi Hou; Bozena Birkenfeld; Hanna Piwowarska-Bilska; Anna Celler
Journal:  EJNMMI Phys       Date:  2017-10-13

5.  From chronic pruritus to neuroendocrine tumor: A case report.

Authors:  Alexandr Ceasovschih; Giorgiana Voloc; Victorița Șorodoc; Dan Vâță; Cristian-Dumitru Lupașcu; Cristina Preda; Cătălina Lionte; Alexandra Stoica; Oana Sîrbu; Elena-Daniela Grigorescu; Raluca Ecaterina Haliga; Adorata Elena Coman; Cristina Bologa; Luminița Gina Vâță; Ovidiu Rusalim Petriș; Gabriela Puha; Gabriela Dumitrescu; Mihai Constantin; Laurențiu Șorodoc
Journal:  Exp Ther Med       Date:  2022-01-04       Impact factor: 2.447

6.  A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.

Authors:  Maria Alejandra Forero Molina; Elizabeth Garcia; Deyanira Gonzalez-Devia; Rafael García-Duperly; Alonso Vera
Journal:  World Allergy Organ J       Date:  2017-09-04       Impact factor: 4.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.